Catalyst Pharmaceuticals (CPRX)

Add to Watchlists
Create an Alert
3.26 -0.14  -4.12% NASDAQ May 25, 17:00 Delayed 2m USD
View Full Chart
CPRX Price Chart
View All Key Stats

CPRX Key Stats

View All CPRX News

CPRX News

View All Events

CPRX Events

Date Type Description
08/10/2018 Misc Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018
08/09/2018 Earnings Catalyst Pharmaceuticals Inc Second Quarter Earnings Results in 2018
05/10/2018 08:30 EDT Misc Catalyst Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018
05/09/2018 Earnings Catalyst Pharmaceuticals Inc First Quarter Earnings Results in 2018
03/14/2018 Earnings Catalyst Pharmaceuticals Inc Fourth Quarter Earnings in 2017 Release
03/14/2018 08:30 EDT Misc Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017
11/09/2017 08:30 EST Misc Catalyst Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017
11/08/2017 Earnings Catalyst Pharmaceuticals Inc Third Quarter Earnings in 2017 Release
08/10/2017 08:30 EDT Misc Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017
08/09/2017 Earnings Catalyst Pharmaceuticals Inc Second Quarter Earnings Results in 2017
View All Performance Charts

CPRX Total Returns Comparison

CPRX Fundamentals

Income Statement View Statement

Revenue (TTM) --
Total Expenses (TTM) 19.93M
Net Income (TTM) -19.15M

Balance Sheet View Statement

Total Assets (Quarterly) 79.13M
Total Liabilities (Quarterly) 2.882M
Shareholders Equity (Quarterly) 76.25M

Cash Flow Statement View Statement

Cash from Operations (TTM) -15.95M
Cash from Investing (TTM) -31.82M
Cash from Financing (TTM) 57.38M

CPRX Ratings

Advertisement

CPRX One Page Reports

CPRX Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 3.26
Price Target Upgrade
Price Target Upside (Daily) Upgrade
Edit

Profile

  • URL: http://www.catalystpharma.com
  • Investor Relations URL: http://ir.catalystpharma.com/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 09, 2018
  • Last Earnings Release: May. 09, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Catalyst Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of therapies for people with rare debilitating diseases, chronic neuromuscular and neurological diseases.

CPRX Comparables

Edit
RXII RXi Pharmaceuticals
MYND MYnd Analytics
SLS SELLAS Life Sciences Group
ACHN Achillion Pharmaceuticals
DXR Daxor

CPRX Excel Add-In Codes

  • Name: =YCI("CPRX","name")
  • Description: =YCI("CPRX","description")
  • Sector: =YCI("CPRX","sector")
  • Industry: =YCI("CPRX","industry")
  • Est. Current Fiscal Year End: =YCI("CPRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Other CPRX Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.